Association of urinary caffeine and caffeine metabolites with cardiovascular disease risk in adults. 2021

Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
State Key Laboratory of Reproductive Medicine, School of Public Health, Nanjing Medical University, Nanjing, China; Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, Nanjing Medical University, Nanjing, China.

Studies have shown that the consumption of a moderate amount of caffeine is associated with a reduced risk of cardiovascular disease (CVD) and may even be protective against CVD. The purpose of the current study was to evaluate the association between urinary caffeine and its related metabolites and CVD risk in a national representative sample of US adults. We analyzed cross-sectional data from the US National Health and Nutrition Examination Survey from 2009 and 2010. The associations between the levels of urinary caffeine metabolites and self-reported CVD, including congestive heart failure, coronary heart disease, angina, heart attack, and stroke, were examined separately in men and women using multivariate logistic regression models adjusted for covariates. In total, 1916 participants (910 men and 1006 women) were included in the analysis. Among women, the odds ratios of CVD in the highest quartiles of 1,3-dimethylxanthine and 1,3,7-trimethylxanthine were 0.33 (95% confidence interval [CI], 0.12-0.92) and 0.35 (95% CI, 0.13-0.93), respectively, compared with the lowest quartiles. Each one-unit (µmol/L) increase in theophylline concentration was associated with a 0.24-mg/dL increase in high-density lipoprotein cholesterol in the fully adjusted model. Among men, no significant association was observed between urinary caffeine metabolites and CVD. Regarding the subtypes of CVD, compared with women in the lowest quartile for 1,3-dimethylxanthine and 1,3,7-trimethylxanthine, the odds of coronary heart disease decreased by 90% (95% CI, -99% to -11%) and 97% (95% CI, -99% to -47%), respectively, in those in the highest quartile. Urinary 1,3-dimethylxanthine and 1,3,7-trimethylxanthine were significantly and inversely associated with CVDs in women. Additional studies are needed to further confirm the results of this study and explore the underlying mechanisms.<END ABSTRACT>.

UI MeSH Term Description Entries
D008297 Male Males
D009749 Nutrition Surveys A systematic collection of factual data pertaining to the nutritional status of a human population within a given geographic area. Data from these surveys are used in preparing NUTRITION ASSESSMENTS. NHANES,National Health and Nutrition Examination Survey,Nutritional Surveys,Nutrition Survey,Nutritional Survey,Survey, Nutrition,Survey, Nutritional,Surveys, Nutrition,Surveys, Nutritional
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios

Related Publications

Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
January 2023, Frontiers in nutrition,
Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
December 2022, Medicine,
Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
July 2023, Nutritional neuroscience,
Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
July 2023, Scientific reports,
Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
November 2022, The Journal of asthma : official journal of the Association for the Care of Asthma,
Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
November 2021, Environmental research,
Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
February 2023, Environmental science and pollution research international,
Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
September 2020, Journal of hazardous materials,
Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
January 1982, Drug metabolism and disposition: the biological fate of chemicals,
Zhenkun Weng, and Cheng Xu, and Jin Xu, and Zhaoyan Jiang, and Qian Liu, and Jingjia Liang, and Aihua Gu
October 1986, British journal of clinical pharmacology,
Copied contents to your clipboard!